Skip to main content

Table 1 Demographic data, duration and rate of propofol infusion at the time of measurements

From: The effect of interruption to propofol sedation on auditory event-related potentials and electroencephalogram in intensive care patients

Patient number/sex Age (years) Length (cm) Weight (kg) Diagnosis Propofol infusiona (mg/kg per hour) Duration of infusionb (hours) Opioidsc
1/M 59 180 86 Thoracic aorta dissection 1.63 31 Oxycodon 10 mg
2/M 53 180 130 Acute myocardial infarction 0.62 11 Fentanyl 0.100 mg/hour
3/M 47 173 68 Pneumonia and sepsis (streptococcal pneumonia) 1.18 13 Oxycodon 3 mg
4/F 47 170 68 Multitrauma (renal rupture, pelvic fracture) 1.76 20 Oxycodon 10 mg
5/M 61 169 96 Ruptured abdominal aortic aneurysm 2.08 19 Fentanyl 0.100 mg/hour
6/M 76 174 73 Acute myocardial infarction and peritonitis 2.47 66 Fentanyl 0.100 mg/hour
7/F 72 160 70 Acute lung injury and status post-AVR+CABG 1.71 10 Oxycodon 5 mg
8/M 66 176 90 Acute lung injury and status post-CABG 4.44 46 Fentanyl 0.150 mg/hour
9/M 68 162 79 Wound infection post-CABG 3.04 112 Oxycodon 35 mg
10/M 64 164 65 Peritonitis and septic shock 1.85 13 Fentanyl 0.200 mg
11/F 70 162 89 Acute myocarial infarction and status post-CABG 0.67 16 Oxacodon 5 mg
12/M 83 167 65 Peritonitis 2.15 19 Fentanyl 0.075 mg
13/M 72 176 96 Sternal dehiscence post-CABG 1.46 14 Oxycodon 36 mg
14/M 76 183 77 Acute myocarial infarction and pulmonary haemorrhage 1.04 18 Oxycodon 10 mg
15/F 71 162 58 Wound infection post-CABG+AVR 1.72 19 Fentanyl 0.150 mg, oxycodon 29 mg
16/M 77 167 73 Acute respiratory distress syndrome 2.74 69 Fentanyl 0.825 mg, oxycodon 15 mg
17/F 50 170 75 Low cardiac output (status post-CABG) 1.60 86 Fentanyl 0.150 mg/hour
18/F 59 165 60 Acute lung injury and septic shock 1.67 12 Oxycodon 3 mg
19/M 71 170 80 Acute myocarial infarction and pulmonary oedema 1.50 14 Oxycodon 18 mg
Mean 65 170 79 - 1.91 31 -
SD 11 7 16 - 0.88 29 -
  1. aRate of propofol infusion at the time of measurements. bNumber of hours of continuous propofol infusion before measurements. cOpioid medication administered during the 12 hours before (total intravenous bolus) and/or during the measurements (infusion rate). AVR, aortic valve replacement; CABG, coronary artery bypass graft.